Brain Metastases Clinical Trials in Cleveland, Ohio
4 studies are recruiting for brain metastases in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
BDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as monotherapy and in combination with other anti-cancer therapies in participants with selected advanced malignancies. The stu…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Cleveland Clinic, Cleveland, Ohio
- Locations
- 49 in total
- Run by
- Institut de Recherches Internationales Servier
-
Development of MRF for Characterization of Brain Tumors After Radiotherapy
The purpose of this study is to discover the potential convenience and ease of using a Magnetic Resonance Imaging (MRI) technique, named Magnetic Resonance Fingerprinting (or MRF), to achieve high-quality images within a short scan time of 5 min for viewing the entire brain. This is an advanced qua…
- Stage
- Not phased
- Ages
- 18 to 60
- Site
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio
- Locations
- 2 in total
- Run by
- Case Comprehensive Cancer Center
-
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Participants in this research study have cancer that has spread to their brain, called brain metastases. One treatment for this type of cancer is called whole brain radiotherapy that stays away from a specific neurocognitive substructure, called the hippocampus, combined with medication to preserve…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio
- Run by
- Case Comprehensive Cancer Center
-
REMASTer: REcurrent Brain Metastases After SRS Trial
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Cleveland Clinic, Cleveland, Ohio
- Locations
- 9 in total
- Run by
- Monteris Medical
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.